About Chris Seibert
Form D filings for KALM Therapeutics in 2024 list Chris Seibert as president and director.
Chris Seibert first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Chris Seibert in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Chris Seibert works with at each company, as listed on that company's latest Form D.
KALM Therapeutics, Inc. · Form D, Aug 9, 2024
AS
Anuj Singhal
Executive officer and director